Back to Search
JAMES WALSH, MD
MD
Ophthalmology Physician
NPI: 1306205703IndividualAccepts Medicare
Education
UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Class of 2016
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement?
PMID 16676776·Sleep·2006
2-rct
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
PMID 17702264·Sleep·2007
2-rct
Understanding GABA and its relation to insomnia and therapeutics.
PMID 17557500·J Clin Sleep Med·2006
8-other
The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
PMID 19345644·Sleep Med·2009
3-trial
Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
PMID 17765013·Sleep Med·2008
4-observational
New technology and new initiatives in U.S. workplace testing.
PMID 17434275·Forensic Sci Int·2008
8-other
Influence of head extension, flexion, and rotation on collapsibility of the passive upper airway.
PMID 18853942·Sleep·2008
8-other
Executioner caspase-3 and caspase-7 are functionally distinct proteases.
PMID 18723680·Proc Natl Acad Sci U S A·2008
7-preclinical
Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction.
PMID 18517036·Sleep·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 517 S EUCLID AVE
SAINT LOUIS, MO 63110 - Phone
- (314) 362-3431
Quick Facts
- NPI
- 1306205703
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile